| http://www.w3.org/ns/prov#value | - Have received MS therapy other than Rebif?? within twelve weeks prior to Screening or at any time during the trial (e.g., other disease modifying drugs, Rebif?? New Formulation, combination therapy, immunomodulatory and/or immunosuppressive agents, including but not limited to any interferon, glatiramer acetate (Copolymer I), cyclophosphamide, cyclosporine, methotrexate, linomide, azathioprine, mi
|
